These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32785976)

  • 1. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
    Koss CA; Charlebois ED; Ayieko J; Kwarisiima D; Kabami J; Balzer LB; Atukunda M; Mwangwa F; Peng J; Mwinike Y; Owaraganise A; Chamie G; Jain V; Sang N; Olilo W; Brown LB; Marquez C; Zhang K; Ruel TD; Camlin CS; Rooney JF; Black D; Clark TD; Gandhi M; Cohen CR; Bukusi EA; Petersen ML; Kamya MR; Havlir DV;
    Lancet HIV; 2020 Apr; 7(4):e249-e261. PubMed ID: 32087152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.
    Lunkuse JF; Kamacooko O; Muturi-Kioi V; Chinyenze K; Kuteesa MO; Price MA; Mayanja Y
    BMC Infect Dis; 2022 May; 22(1):467. PubMed ID: 35578163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative Assessment of Barriers and Facilitators of PrEP Use Before and After Rollout of a PrEP Program for Priority Populations in South-central Uganda.
    Ddaaki W; Strömdahl S; Yeh PT; Rosen JG; Jackson J; Nakyanjo N; Kagaayi J; Kigozi G; Nakigozi G; Grabowski MK; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Kennedy CE
    AIDS Behav; 2021 Nov; 25(11):3547-3562. PubMed ID: 34240317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda.
    Kusemererwa S; Kansiime S; Mutonyi G; Namirembe A; Katana S; Kitonsa J; Kakande A; Okello JM; Kaleebu P; Ruzagira E
    Medicine (Baltimore); 2021 Nov; 100(44):e27719. PubMed ID: 34871265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda.
    Mayer CM; Owaraganise A; Kabami J; Kwarisiima D; Koss CA; Charlebois ED; Kamya MR; Petersen ML; Havlir DV; Jewell BL
    J Int AIDS Soc; 2019 Apr; 22(4):e25276. PubMed ID: 31037845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and Persistent Use of HIV Preexposure Prophylaxis Among Key Populations: Results From Ukraine's Scaled National Preexposure Prophylaxis Program.
    Vitruk O; Ihnatiuk AP; Kazanzhy AP; Shvab M; Sharma M; Manhart LE; Hetman LI; Shapoval AY; Puttkammer NH
    J Acquir Immune Defic Syndr; 2024 Jul; 96(3):241-249. PubMed ID: 38905475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual pleasure and HIV-related worry in female sex workers on oral pre-exposure prophylaxis in south-western Uganda.
    Nakiganda LJ; Bavinton BR; Poynten IM; Serwadda D; Bazaale JM; Grulich AE
    Sex Health; 2024 Jan; 21():. PubMed ID: 38267368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda.
    Ssuna B; Katahoire A; Armstrong-Hough M; Kalibbala D; Kalyango JN; Kiweewa FM
    BMC Public Health; 2022 Mar; 22(1):468. PubMed ID: 35264123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in an mHealth App Aiming to Promote the Use of HIV Pre-Exposure Prophylaxis Among Female Sex Workers in Dar es Salaam, Tanzania: Prospective Cohort Study.
    Mbotwa CH; Kazaura MR; Moen K; Leshabari MT; Metta E; Mmbaga EJ
    JMIR Mhealth Uhealth; 2023 Oct; 11():e46853. PubMed ID: 37855221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported and pill count measures of adherence to oral HIV PrEP among female sex workers living in South-Western Uganda.
    Nakiganda LJ; Grulich AE; Poynten IM; Serwadda D; Bazaale JM; Jin J; Bavinton BR
    PLoS One; 2022; 17(11):e0277226. PubMed ID: 36355810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review.
    Mpirirwe R; Segawa I; Ojiambo KO; Kamacooko O; Nangendo J; Semitala FC; Kyambadde P; Kalyango JN; Kiragga A; Karamagi C; Katahoire A; Kamya M; Mujugira A
    BMJ Open; 2024 Apr; 14(4):e076545. PubMed ID: 38670600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and continuation of HIV pre-exposure prophylaxis among women of reproductive age in two health facilities in Kisumu County, Kenya.
    Ogolla M; Nyabiage OL; Musingila P; Gachau S; Odero TMA; Odoyo-June E; Ochanda B; Appolonia A; Katiku E; Joseph R; Ogolla C; Otieno L; Odhiambo F; Truong HM
    J Int AIDS Soc; 2023 Mar; 26(3):e26069. PubMed ID: 36912204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in eThekwini, South Africa, 2016-2020.
    Rao A; Mhlophe H; Comins C; Young K; Mcingana M; Lesko C; Mulumba N; Baral S; Hausler H; Schwartz S
    PLoS One; 2022; 17(3):e0265434. PubMed ID: 35290421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.